<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        0505257333
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2013
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        ACUVAIL ophthalmic solution
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        KETOROLAC TROMETHAMINE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        0.45
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Ophthalmic use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Ophthalmic solution
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        0
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        30
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Single Dose Container
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        NCE
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        24
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 30°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        35.45
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="ALLERGAN" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            ALLERGAN
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 359]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            Cigalah Group
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            AbbVie Inc
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        S01BC05
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>ACUVAIL&trade; belongs to a group of medicines known as non-steroidal anti-inflammatory drugs (NSAIDs).</p><p>&nbsp;</p><p>&nbsp;ACUVAIL&trade; ophthalmic solution is indicated for the treatment of pain and inflammation following cataract surgery.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Do not use Acuvail &trade;</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you are allergic (hypersensitive) to ketorolac tromethamine or any of the other ingredients of Acuvail &trade;</p><p>&nbsp;</p><p>Take special care with Acuvail &trade;</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you have had a disease of the cornea (the transparent layer that covers the coloured part of the eye)</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you have developed allergies to acetylsalicylic acid, phenylacetic acid derivatives or other non-steroidal anti-inflammatory agents in the past</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you have had complicated ocular surgeries or have corneal denervation, corneal epithelial defects, diabetes mellitus, ocular surface diseases (e.g., dry eye syndrome), rheumatoid arthritis, or repeat ocular surgeries within a short period of time</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you are prone to bleeding or using other medications which may prolong bleeding time</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &bull;&nbsp;&nbsp;&nbsp; If you have slow or delay in healing.</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &bull;&nbsp;&nbsp;&nbsp; If you have asthma.</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If you wear contact lenses. Do not use Acuvail &trade; while your contact lenses are in your eyes.</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>Using other medicines, herbal or dietary supplements</p><p>Please tell your doctor, healthcare provider or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription. In particular, inform your doctor or pharmacist if you are taking;</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Other medicines which may prolong bleeding time</p><p>&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Other topical steroids, as using topical steroids and topical NSAIDs at the same time may increase the potential for healing problems</p><p>&nbsp;</p><p>If you use Acuvail &trade; with another eye medicine, leave at least 5 minutes between putting in Acuvail &trade;and the other medicine.</p><p>&nbsp;</p><p>&nbsp;</p><p>Pregnancy and breast-feeding</p><p>Ask your doctor, healthcare provider or pharmacist for advice before taking any medicine.</p><p>&nbsp;</p><p>&nbsp;</p><p>Pregnancy:</p><p>There are no adequate and well-controlled studies with ACUVAIL in pregnant women. No evidence of teratogenicity has been observed in rats or rabbits with ACUVAIL at clinically relevant doses.</p><p>&nbsp;</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Breast-feeding:</p><p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; It is not known whether ketorolac when given topically is present in human milk. Because many drugs are excreted in human milk, caution should be exercised when Acuvail &trade; is administered to a nursing woman.</p><p>&nbsp;</p><p>&nbsp;</p><p>Driving and using machines</p><p>If temporary blurred vision occurs during installation, wait until your vision becomes clear before driving or using machines.</p><p>&nbsp;</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Always use Acuvail &trade;exactly as your doctor or healthcare provider has told you. You should check with your doctor, healthcare provider or pharmacist if you are not sure.</p><p>&nbsp;</p><p>&nbsp;</p><p>Instructions for proper use Dosage:</p><p>One drop of <strong>ACUVAIL&trade; </strong>should be applied to the affected eye twice daily beginning 1 day&nbsp;&nbsp; prior to cataract surgery, continued on the day of surgery, and through the first 2 weeks of the postoperative period.</p><p>&nbsp;</p><p>&nbsp;</p><p><strong>Method of administration</strong></p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p><strong>​​​​​​</strong><img alt="" width="570" height="238" src="data:image/png;base64,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" /></p><p>1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Wash your hands before using your medication. Tilt your head back and look up.</p><p>2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Pull down your lower eyelid slowly to create a small pocket.</p><p>3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Turn the bottle upside down and squeeze it such that one drop is put into each eye which should be treated.</p><p>4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Release you eyelid and keep your eyes closed for 30 second.</p><p>&nbsp;</p><p>&nbsp;</p><p>If a drop misses your eye, try again.</p><p>&nbsp;</p><p>To keep the eye drops free from contamination, do not let the tip of the single use vial touch your eye or anything else</p><p>&nbsp;To avoid the potential for cross-contamination, use one single use vial for each eye following bilateral ocular surgery. The use of the same single use vial of topical eye drops for both eyes following bilateral ocular surgery is not recommended.</p><p>&nbsp;</p><p>Use the single use vial immediately after opening for administration to the affected eye. The remaining vial contents should be discarded.</p><p>&nbsp;</p><p>Avoid allowing the tip of the single-dose vial to contact the eye or surrounding structures because this could cause the tip to become contaminated by common bacteria known to cause ocular infections or cause injury to the eye. Serious damage to the eye and subsequent loss of vision may result from using contaminated solutions.</p><p>&nbsp;</p><p>Store the vials in the pouch, protected from light. Fold pouch ends closed.</p><p>&nbsp;</p><p>&nbsp;</p><p><strong>Children and Adolescent Use:</strong></p><p>The safety and effectiveness of ACUVAIL have not been established in children younger than 2 years old</p><p>&nbsp;</p><p><strong>Elderly Use:</strong></p><p>No dose adjustment is needed for elderly patients</p><p>&nbsp;</p><p>&nbsp;</p><p>If you take more ACUVAIL&trade; than you should</p><p>If you take more ACUVAIL&trade; than you should, consult your doctor, health provider or pharmacist</p><p>&nbsp;</p><p>If you forget to take ACUVAIL&trade;</p><p>If you forget a dose apply it as soon as you remember, unless it is almost time for your next dose, in which case you should miss out the forgotten dose. Then take your next dose as usual and continue with your normal routine.</p><p>Do not take a double dose to make up for a forgotten dose.</p><p>&nbsp;</p><p>&nbsp;</p><p>If you stop using ACUVAIL&trade;</p><p>Discontinuation of ACUVAIL&trade; therapy is not expected to create a negative effect.</p><p>&nbsp;</p><p>If you have any further questions on the use of this product, ask your doctor, healthcare provider or pharmacist.</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Like all medicines, ACUVAIL&trade; can cause side effects, although not everybody gets them.</p><p>&nbsp;</p><p>Common:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Increased intraocular pressure</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Conjunctival hyperemia and/or hemorrhage</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Corneal edema</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Ocular pain</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Headache</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Tearing and vision blurred</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Increased intraocular pressure</p><p><s>&nbsp;</s></p><p>Unknown:</p><p>&nbsp;</p><p>Eye Disorders:</p><p>&middot; Corneal erosion</p><p>&middot; Corneal perforation</p><p>&middot; Corneal thinning &amp; corneal melt</p><p>&middot; Epithelial breakdown</p><p>&middot; Ulcerative keratitis&nbsp;&nbsp;</p><p>&nbsp;</p><p>Respiratory, Thoracic and Mediastinal Disorders:</p><p>&middot; Bronchospasm</p><p>&middot; Exacerbation of asthma</p><p>&nbsp;</p><p>&nbsp;</p><p>If any of the side effects get serious, or if you notice any side effects not listed in this leaflet, please tell you doctor, healthcare provider or pharmacist.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Keep out of the reach and sight of children</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>Store below 30&deg; C. Store the vials in the pouch, protected from light. Fold pouch ends closed.</p><p>&nbsp;</p><p>The solution from one individual single-dose vial is to be used immediately after opening. The remaining vial contents should be discarded.</p><p>&nbsp;</p><p>Do not use ACUVAIL&trade; after the expiry date which is stated on the package. The expiry date refers to the last day of that month.</p><p>&nbsp;</p><p>Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>The active substance is ketorolac tromethamine, 0.45%. The other ingredients are Carboxymethylcellulose sodium, sodium chloride, sodium citrate dehydrate, purified water and sodium hydroxide and/or hydrochloric acid to adjust pH.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                ACUVAIL™ is supplied as sterile, clear, and colorless to pale yellow ophthalmic solution in clear low density polyethylene (LDPE), single- dose vials packaged in 3 flow wrap pouches, 10 vials per flow Wrap pouch:
30 Single-Use dose Vials 0.4 mL each (Carton containing 3 flow wraps). 

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Marketing Authorization Holder:</p><p>AbbVie Inc.,</p><p>1 North Waukegan Road,</p><p>North Chicago, IL 60064 USA</p><p>&nbsp;</p><p><strong>Manufacturer: </strong>Allergan Sales LLC, Waco, USA</p><p>Telephone: (254) 666-8660</p><p>Fax: (254) 666-3012</p><p>&nbsp;</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                This leaflet was prepared in May 2024
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL">ينتمي أكيوفيل&trade; إلى مجموعة من الأدوية تُعرف باسم مضادات الالتهاب اللاستيرويدية (NSAIDs).</p><p dir="RTL">&nbsp;</p><p dir="RTL">صُمم محلول العيون أكيوفيل&trade; لعلاج الألم والالتهاب التالي لجراحة المياه البيضاء.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>لا تستخدم أكيوفيل&trade;</strong></p><ul><li dir="RTL">إذا كان لديك حساسية (حساسية مفرطة) لمادة كيتورولاك تروميثامين أو لأي مكون من المكونات الأخرى لقطرة أكيوفيل&trade;.</li></ul><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>يجب توخي الحرص الشديد عند استخدام أكيوفيل&trade;</strong></p><ul><li dir="RTL">إذا كان لديك مرض في القرنية (الطبقة الشفافة التي تغطي الجزء الملون من العين)</li><li dir="RTL">إذا ظهر لديك سابقاً أنواع حساسية لمشتقات حمض أسيتيل سليسيليك أو مشتقات حمض فينيل أسيتيك أو مضادات الالتهاب اللاستيرويدية الأخرى</li><li dir="RTL">إذا كنت قد خضعت لجراحات مُعقَّدة في العين أو عملية إزالة تعصيب القرنية أو أصبت بتشوهات الغشاء الطلائي للقرنية أو مرض السكري أو أمراض في سطح العين (مثل متلازمة العين الجافة) أو التهاب المفاصل&nbsp;الرّوماتويدي أو جراحات عين متعددة خلال فترة قصيرة من الوقت</li><li dir="RTL">إذا كنت عرضة للنزيف أو تستخدم أدوية أخرى قد تتسبب في إطالة وقت النزيف</li></ul><p dir="RTL">&nbsp;</p><ul><li dir="RTL">إذا كنت مصاباً ببطءٍ أو تأخُّرٍ في عملية الشفاء.</li><li dir="RTL">إذا كنت تعاني من الربو<strong>&nbsp;&nbsp;&nbsp;&nbsp; </strong></li><li dir="RTL">إذا كنت ترتدي عدسات لاصقة. لا تستخدم أكيوفيل&trade; إذا كانت العدسات اللاصقة داخل عينيك.</li></ul><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>استخدام الأدوية الأخرى أو الأعشاب أو المكملات الغذائية</strong></p><p dir="RTL">يُرجى إبلاغ الطبيب أو مزود الرعاية الصحية أو الصيدلي إذا كنت تتناول حالياً أو تناولت بالفعل أدوية أخرى، بما في ذلك الأدوية التي تحصل عليها دون وصفة طبية. على وجه التحديد، أخبر طبيبك أو الصيدلي إذا كنت تتناول:</p><ul><li dir="RTL">أدوية أخرى قد تطيل زمن النزيف</li><li dir="RTL">ستيرويدات موضعية أخرى، فقد يؤدي استخدام الستيرويدات الموضعية ومضادات الالتهاب اللاستيرويدية الموضعية في نفس الوقت إلى زيادة خطر الإصابة بمشكلات في معدل الشفاء</li></ul><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL">إذا كنت تستخدم أكيوفيل&trade; مع دواء آخر خاص بالعين فافصل بين استخدام أكيوفيل&trade; والدواء الآخر بـ 5 دقائق على الأقل.</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>الحمل والرضاعة</strong></p><p dir="RTL">استشيري طبيبك أو مزود الرعاية الصحية أو الصيدلي قبل تناول أي دواء.</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>الحمل:</strong></p><p dir="RTL">لا توجد دراسات كافية ومعدة بشكل جيد للنساء الحوامل و أكيوفيل&trade;. ليس هنالك دليل على تشوهات خلقية بإستخدام جرعات أكيوفيل&trade; السريرية على الفئران والأرانب</p><p dir="RTL"><strong>الرضاعة الطبيعية:</strong></p><p dir="RTL">ليس من المعروف ما إذا كان كيتورولاك يفرز في حليب الأم عند استخدامه موضعياً أم لا. لأن العديد من العقاقير تُفرز في حليب الأم، يجب توخي الحرص الشديد عندما يوصف أكيوفيل&trade; للمرأة المرضعة.</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>القيادة وتشغيل الآلات</strong></p><p dir="RTL">في حال حدوث غشاوة مؤقتة في الرؤية أثناء وضع القطرة، انتظر حتى تصبح الرؤية واضحة قبل القيادة أو استخدام الآلات.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">استخدم أكيوفيل&trade; دائماً وفقاً لإرشادات الطبيب أو مزود الرعاية الصحية. يجب استشارة الطبيب أو مزود الرعاية الصحية أو الصيدلي إذا لم تكن متأكداً.</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>إرشادات الاستعمال الصحيح</strong></p><p dir="RTL"><strong>الجرعة:</strong></p><p dir="RTL">يجب وضع قطرة واحدة من محلول أكيوفيل&trade; في العين المصابة مرتين يومياً، وذلك قبل جراحة المياه البيضاء بيوم واحد، ويتواصل الاستخدام في يوم الجراحة وخلال أول أسبوعين من الفترة التالية للجراحة.</p><p dir="RTL"><strong>&nbsp;</strong></p><p><strong>طريقة الاستعمال</strong></p><p><strong><img alt="" width="540" height="226" src="data:image/png;base64,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" /></strong></p><p>&nbsp;</p><p>&nbsp;</p><p dir="RTL">1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اغسل يديك قبل استخدام دوائك. قم بإمالة رأسك إلى الوراء وانظر إلى أعلى</p><p dir="RTL">2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اسحب جفنك السفلي ببطء لتكوين جيب صغير.</p><p dir="RTL">3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; اقلب الزجاجة من أعلى إلى أسفل واضغط عليها بحيث تخرج قطرة واحدة في كل عين تحتاج إلى العلاج.</p><p dir="RTL">4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; حرر جفنك وأغلق عينيك لمدة 30 ثانية.</p><p dir="RTL">&nbsp;</p><p dir="RTL">إذا لم تدخل القطرة داخل عينك فكرر المحاولة مرة أخرى.</p><p dir="RTL">&nbsp;</p><p dir="RTL">للحفاظ على قطرة العين من التلوث، لا تدع طرف الزجاجة المخصصة للاستخدام مرة واحدة تلمس عينك أو أي شيء آخر</p><p dir="RTL">لتجنب خطر حدوث التلوث العرضي، استخدم زجاجة مخصصة للاستخدام مرة واحدة لكل عين بعد إجراء جراحة في كلتا العينين. لا يُنصح باستخدام نفس الزجاجة المخصصة للاستخدام مرة واحدة من قطرة العين الموضعية بعد إجراء جراحة في كلتا العينين.</p><p dir="RTL">استخدم الزجاجة المخصصة للاستخدام لمرة واحدة مباشرةً بعد فتحها وضعها في العين المصابة. يجب التخلص مما تبقَّى من محتويات الزجاجة.</p><p dir="RTL">&nbsp;</p><p dir="RTL">تجنب تلامس طرف الزجاجة المخصصة للاستخدام الواحد بالعينين او الاجزاء المحيطية وذلك بسبب إمكانيتهم بالتلوث ببكتيريا قد تسبب إلتهاب العين او تسبب إصابة بالعين. قد يسبب إستخدام قطرة ملوثه ضرر شديد للعين وفقدان للبصر لاحقًا.</p><p dir="RTL">تُحفَظ الزجاجات داخل الحافظة لحمايتها من الضوء. تُطوَى نهايات الحافظة لغلقها.</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL">الاستعمال مع الأطفال:</p><p dir="RTL">&nbsp;</p><p dir="RTL">لم يتم التأكد من فعالية وسلامة أكيوفيل&trade; للأطفال أقل من سنتين.</p><p dir="RTL">&nbsp;</p><p dir="RTL">الاستعمال مع كبار السن:</p><p dir="RTL">لا تحتاج الجرعة إلى تعديل عند الاستخدام من قِبل المرضى من كبار السن</p><p dir="RTL">&nbsp;</p><p dir="RTL">&nbsp;</p><p dir="RTL"><strong>في حال تناول جرعة زائدة من أكيوفيل&trade; </strong></p><p dir="RTL">في حال تناول جرعة زائدة من أكيوفيل&trade;، فاستشر الطبيب أو مزود الرعاية الصحية أو الصيدلي</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>إذا نسيت تناول أكيوفيل&trade;</strong></p><p dir="RTL">إذا نسيت تناول إحدى الجرعات فاستخدم القطرة بمجرد تذكرك، إلا إذا اقترب موعد تناول الجرعة التالية، وفي هذه الحالة لا تتناول الجرعة الفائتة. ثم تناول جرعتك التالية في وقتها المعتاد وواصل روتينك الطبيعي.</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL">لا تتناول جرعة مضاعفة لتعويض الجرعة التي نسيتها.</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>في حال التوقف عن استخدام أكيوفيل&trade;</strong></p><p dir="RTL">&nbsp;من غير المتوقع أن يتسبب التوقف عن تناول أكيوفيل&trade; في إحداث مفعول سلبي.</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL">إذا كان لديك مزيد من الأسئلة حول استخدام هذا المنتج، فاسأل الطبيب أو مزود الرعاية الصحية أو الصيدلي.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>شأنه شأن جميع الأدوية الأخرى، قد ينتج عن استخدام أكيوفيل&trade; آثار جانبية، بالرغم من عدم ظهورها على جميع الأشخاص. </strong></p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL">آثار جانبية شائعة:</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; زيادة الضغط داخل العين</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; فرط الدم و/أو النزيف داخل ملتحمة العين</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; وذمة في القرنية</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ألم داخل العين</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; الصداع</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; كثرة إفراز الدموع والرؤية الضبابية</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; زيادة الضغط داخل العين</p><p dir="RTL">&nbsp;</p><p dir="RTL">آثار جانبية غير معروفة:</p><p dir="RTL">&nbsp;</p><p dir="RTL">إضطرابات العين:</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تآكل القرنية &nbsp;</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ثقب القرنية</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ترقق القرنية وذوبان القرنية</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; تحلل الغشاء الطلائي</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; التهاب القرنية القرحي</p><p dir="RTL">&nbsp;</p><p dir="RTL">إضطرابات الجهاز التنفسي والصدر:</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ضيق في الشعب الهوائية.</p><p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ازدياد فى حده الازمه التنفسيه</p><p dir="RTL">&nbsp;</p><p dir="RTL">إذا ازدادت حدة أي من هذه الآثار الجانبية، أو لاحظت ظهور أي آثار جانبية أخرى غير مدرجة في هذه النشرة، يُرجى إخبار الطبيب أو مزود الرعاية الصحية أو الصيدلي.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">يُحفَظ بعيداً عن متناول أيدي الأطفال ومرمى أبصارهم.</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL">يُحفظ في درجة حرارة أقل من 30&deg; مئوية. تُحفظ الزجاجات داخل الحافظة لحمايتها من الضوء. تطوى نهايات الحافظة لغلقها. لا تستخدم أكيوفيل&trade; بعد تاريخ انتهاء الصلاحية المدون على العلبة. يشير تاريخ الصلاحية إلى اليوم الأخير من الشهر المذكور.</p><p dir="RTL">&nbsp;</p><p dir="RTL">يجب إستخدام المحلول المعد بزجاجة للإستخدام الواحد فورًا بعد الفتح ويجب التخلص من الكمية المتبقية من الزجاجة.</p><p dir="RTL">&nbsp;</p><p dir="RTL">لا ينبغي التخلص من الأدوية عن طريق مياه الصرف أو النفايات المنزلية. اسأل الصيدلي عن طريقة التخلص من الأدوية التي لم تعد تحتاج إليها. تساعد هذه التدابير في حماية البيئة.</p><p dir="RTL"><strong>&nbsp;</strong></p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">&bull;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; المادة الفعَّالة هي: كيتورولاك تروميثامين، 0.45%.</p><p dir="RTL">المكونات الأخرى هي:&nbsp;كَرْبُوكْسِي ميثيل سليولوز الصوديوم، وكلوريد صوديوم، دي هيدرات سترات الصوديوم، وماء نقي، وهيدروكسيد صوديوم و/أو حمض هيدروكلوريك لضبط درجة الحموضة.</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">يتوفر أكيوفيل&trade; في شكل محلول للعين معقم شفاف عديم اللون إلى لون أصفر باهت يأتي في زجاجات شفافة مخصصة للاستخدام مرة واحدة فقط مصنوعة من مادة البولي إثيلين المنخفض الكثافة، معبأة داخل 3 حافظات مصنوعة من الرقائق المعدنية، 10 زجاجات في كل حافظة:</p><p dir="RTL">30 زجاجة للاستخدام مرة واحدة كل منها 0.4 مل</p><p dir="RTL"><strong>&nbsp;</strong></p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>الشركة صاحبة ترخيص التسويق:</strong></p><p dir="RTL">أبفي إنك.، 1 ان طريق وكيجان</p><p dir="RTL">نورث شيكاغو، آي إل ٦٠٠٦٤،</p><p dir="RTL">الولايات المتحدة الأمريكية&nbsp;</p><p dir="RTL"><strong>&nbsp;</strong></p><p dir="RTL"><strong>الشركة المُصنعة: أليرجان للمبيعات ذ.م.م، واكو، الولايات المتحدة الأمريكية</strong></p><p dir="RTL">هاتف رقم: (254) 666-8660</p><p dir="RTL">فاكس: (254) 666-3012</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            أُعدت هذه النشرة في مايو 2024
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                ACUVAIL (ketorolac tromethamine ophthalmic solution) 0.45%, for topical ophthalmic use.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Active substance:
Ketorolac tromethamine 0.45%

For a full list of excipients, see section 6.1



            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Sterile ophthalmic solution.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; ACUVAIL </strong>is indicated for the treatment of pain and inflammation following cataract surgery.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>&nbsp; Apply One Drop of <strong>ACUVAIL </strong>to the affected eye twice daily beginning 1 day &nbsp;&nbsp;prior to cataract surgery, continued on the day of surgery, and through the first 2 weeks of the postoperative period.</p><p>&nbsp;</p><p>&nbsp;</p><p><strong>ACUVAIL </strong>may be administered in conjunction with other topical ophthalmic medications such as alpha-agonists, beta-blockers, carbonic anhydrase inhibitors, cycloplegics, and mydriatics. Drops should be administered at least 5 minutes apart.</p><p>&nbsp;</p><p><strong>Pediatric Use:</strong></p><p>The safety and effectiveness of ACUVAILL have not been established in pediatric patients younger than 2 years old.</p><p>&nbsp;</p><p><strong>Geriatric Use:</strong></p><p>No overall differences in safety or effectiveness have been observed between elderly and other adult patients.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                ACUVAIL is contraindicated in patients with previously demonstrated hypersensitivity to any of the ingredients in the formulation.
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Delayed Healing</strong></p><p>Topical nonsteroidal anti-inflammatory drugs (NSAIDs) may slow or delay healing. Topical corticosteroids are also known to slow or delay healing. Concomitant use of topical NSAIDs and topical steroids may increase the potential for healing problems.</p><p><strong>&nbsp;</strong></p><p><strong>Cross-Sensitivity or Hypersensitivity</strong></p><p>There is the potential for cross-sensitivity to acetylsalicylic acid, phenylacetic acid derivatives, and other NSAIDs. There have been reports of bronchospasm or exacerbation of asthma associated with the use of ketorolac tromethamine ophthalmic solution in patients who either have a known hypersensitivity to aspirin/non-steroidal anti-inflammatory drugs, or a past medical history of asthma. Therefore, caution should be used when treating individuals who have previously exhibited sensitivities to these drugs.</p><p><strong>&nbsp;</strong></p><p><strong>&nbsp;Increased Bleeding Time</strong></p><p>With some NSAIDs, there exists the potential for increased bleeding time due to interference with thrombocyte aggregation. There have been reports that ocularly applied nonsteroidal anti-inflammatory drugs may cause increased bleeding of ocular tissues (including hyphemas) in conjunction with ocular surgery.</p><p>&nbsp;</p><p>It is recommended that <strong>ACUVAIL </strong>be used with caution in patients with known bleeding tendencies or who are receiving other medications, which may prolong bleeding time.</p><p><strong>&nbsp;</strong></p><p><strong>Corneal Effects</strong></p><p>Use of topical NSAIDs may result in keratitis. In some susceptible patients, continued use of topical NSAIDs may result in epithelial breakdown, corneal thinning, corneal erosion, corneal ulceration, or corneal perforation. These events may be sight threatening. Patients with evidence of corneal epithelial breakdown should immediately discontinue use of topical NSAIDs and should be closely monitored for corneal health.</p><p>&nbsp;</p><p>Postmarketing experience with topical NSAIDs suggests that patients with complicated ocular surgeries, corneal denervation, corneal epithelial defects, diabetes mellitus, ocular surface diseases (e.g., dry eye syndrome), rheumatoid arthritis, or repeat ocular surgeries within a short period of time may be at increased risk for corneal adverse events which may become sight threatening.</p><p>Topical NSAIDs should be used with caution in these patients.</p><p>&nbsp;</p><p>Postmarketing experience with topical NSAIDs also suggests that use more than 1 day prior to surgery or use beyond 14 days postsurgery may increase patient risk for the occurrence and severity of corneal adverse events.</p><p><strong>&nbsp;</strong></p><p><strong>Contact Lens Wear</strong></p><p><strong>ACUVAIL </strong>should not be administered while wearing contact lenses.</p><p>&nbsp;</p><p><strong>Risk of Contamination</strong></p><p>Avoid allowing the tip of the single-dose vial to contact the eye or surrounding structures because this could cause the tip to become contaminated by common bacteria known to cause ocular infections or cause injury to the eye. Serious damage to the eye and subsequent loss of vision may result from using contaminated solutions.</p><p><strong>&nbsp;</strong></p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p><strong>PATIENT INFORMATION</strong></p><p><strong>&nbsp;</strong></p><p>Avoiding Contamination of the Product</p><p>Patients should be instructed that the solution from one individual single-use vial is to be used immediately after opening for administration to the affected eye. The remaining vial contents should be discarded.</p><p>&nbsp;</p><p>The use of the same single-use vial of topical eye drops for both eyes following bilateral ocular surgery is not recommended. In these circumstances, advise patients to use one vial for each eye immediately after opening and discard the remaining contents after use.</p><p>&nbsp;</p><p>Patients should be instructed to avoid allowing the tip of the vial to contact the eye or surrounding structures because this could cause the tip to become contaminated by common bacteria known to cause ocular infections or cause injury to the eye. Serious damage to the eye and subsequent loss of vision may result from using contaminated solutions.</p><p>&nbsp;</p><p>Store the vials in the pouch, protected from light. Fold pouch ends closed.</p><p><strong>&nbsp;</strong></p><p>&nbsp;Intercurrent Ocular Conditions</p><p>Patients should be advised that if they develop an intercurrent ocular condition (e.g., trauma or infection) or have ocular surgery, they should immediately seek their physician&rsquo;s advice concerning the continued use of <strong>ACUVAIL</strong>.</p><p>&nbsp;</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>ACUVAIL ophthalmic solution may be administered in conjunction with other topical</p><p>ophthalmic medications such as alpha-agonists, antibiotics, beta blockers, carbonic anhydrase inhibitors, cycloplegics, and mydriatics.</p><p>Patients should be advised that if more than one topical ophthalmic medication is being used, the medicines should be administered at least 5 minutes apart.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>Fertility</strong></p><p>&nbsp;</p><p>Ketorolac tromethamine did not impair fertility when administered orally to male and female rats at doses up to 9 mg/kg/day and 16 mg/kg/day, respectively. These doses are respectively 1500 and 2700 times higher than the typical human topical ophthalmic daily dose.</p><p>&nbsp;</p><p><strong>Pregnancy</strong></p><p><strong>&nbsp;</strong></p><p><u>Risk Summary</u></p><p>There are no adequate and well-controlled studies with ACUVAIL in pregnant women. No evidence of teratogenicity has been observed in rats or rabbits with ACUVAIL at clinically relevant doses.</p><p><s>&nbsp;</s></p><p><strong>Lactation:</strong></p><p><strong>&nbsp;</strong></p><p><u>Risk Summary</u></p><p><u>&nbsp;</u></p><p>It is not known whether are whether ketorolac when given topically is present in human milk. Because many drugs are excreted in human milk, caution should be exercised when <strong>ACUVAIL </strong>is administered to a nursing woman.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>There are no reported effects of topical ophthalmic drugs on driving or using machinery. However, caution should be exercised. If transient blurred vision occurs during installation, the patient should wait until the vision is restored.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Because clinical<s> </s>trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to the rates in the clinical trials of another drug and may not reflect the rates observed in practice.</p><p>&nbsp;</p><p>Frequency categories: Very common (&ge;1/10); common (&ge;1/100 to &lt;1/10); uncommon (&ge;1/1,000 to &le;1/100); rare (&ge;1/10,000 to &le;1/1,000); very rare (&le;1/10,000), not known (cannot be estimated from the available data).</p><p><strong>&nbsp;</strong></p><p><strong>Clinical Studies Experience</strong></p><p>The most common adverse reactions were reported in 1% to 6% of patients.</p><p>Common:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Increased intraocular pressure</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Conjunctival hyperemia and/or hemorrhage</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Corneal edema</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Ocular pain</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Headache</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Tearing and vision blurred</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Increased intraocular pressure</p><p>&nbsp;</p><p>Other adverse reactions occurring during treatment with ketorolac tromethamine ophthalmic solutions included allergic reactions (including eye swelling, hyperemia, and pruritis).</p><p>&nbsp;</p><p><strong>Postmarketing Experience </strong></p><p>The following adverse reactions have been identified during postapproval use of ketorolac tromethamine ophthalmic solutions in clinical practice. Because these reactions are reported voluntarily from a population uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relation to the drug.</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p>Unknown:</p><p>&nbsp;</p><p>Eye Disorders:</p><p>&middot; Corneal erosion</p><p>&middot; Corneal perforation</p><p>&middot; Corneal thinning &amp; corneal melt</p><p>&middot; Epithelial breakdown</p><p>&middot; Ulcerative keratitis</p><p>&nbsp;</p><p>Respiratory, Thoracic and Mediastinal Disorders:</p><p>&middot; Bronchospasm</p><p>&middot; Exacerbation of asthma</p><p><u>To reports any side effect(s): </u></p><p><strong>Saudi Arabia:</strong></p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>&middot; The National Pharmacovigilance Centre (NPC):</p><p>- SFDA Call Center: 19999</p><p>- E-mail: npc.drug@sfda.gov.sa</p><p>- Website: https://ade.sfda.gov.sa/</p><p><strong>&nbsp;</strong></p></td></tr></tbody></table><p><strong>&nbsp;</strong></p><p><strong>Other GCC States:</strong></p><table border="1" cellspacing="0" cellpadding="0"><tbody><tr><td style="vertical-align:top"><p>- Please contact the relevant competent authority.</p></td></tr></tbody></table><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No overdosage has been reported after ophthalmic use. In case of an overdosage, symptomatic and supportive treatment should be instituted and must be diluted with plenty of water.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Pharmacotherapeutic group: Non-steroidal anti-inflammatory (NSAID) ATC Code: S01BC05</p><p>Mechanism of Action</p><p>Ketorolac tromethamine is a nonsteroidal anti-inflammatory drug which, when administered systemically, has demonstrated analgesic, anti-inflammatory, and anti-pyretic activity. The mechanism of its action is thought to be due to its ability to inhibit prostaglandin biosynthesis.</p><p>&nbsp;</p><p>&nbsp;</p><p>&nbsp;</p><p><strong>CLINICAL STUDIES </strong></p><p>&nbsp;</p><p>Two multicenter, randomized, double-masked, parallel group comparison studies including approximately 500 patients were conducted to evaluate the effects of <strong>ACUVAIL </strong>on anterior chamber cell and flare, and ocular pain relief following cataract extraction with posterior chamber intraocular lens (IOL) implantation. Results of these studies indicated that patients receiving <strong>ACUVAILL&trade; </strong>had a significantly higher incidence of clearing of anterior chamber inflammation 53% (167/318) vs. patients receiving vehicle 26% (41/155) at day 14.</p><p><strong>&nbsp;</strong></p><p><strong>ACUVAIL </strong>was also significantly superior to vehicle in resolving ocular pain. On Day 1 post cataract surgery, 72% (233/322) of patients in the <strong>ACUVAIL </strong>group were pain free compared to 40% (62/156) of patients in the vehicle group.</p><p>&nbsp;</p><p>Results from clinical studies indicate that ketorolac tromethamine has no significant effect upon intraocular pressure; however, changes in intraocular pressure may occur following cataract surgery.</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Two drops of 0.5% ketorolac tromethamine ophthalmic solution instilled into the eyes of patients 12 hours and 1 hour prior to cataract extraction achieved a mean ketorolac concentration of 95 ng/mL in the aqueous humor of 8 of 9 eyes tested (range 40 to 170 ng/mL).</p><p>&nbsp;</p><p>One drop of 0.5% ketorolac tromethamine ophthalmic solution was instilled into 1 eye and 1 drop of vehicle into the other eye three times daily in 26 healthy subjects. Five (5) of 26 subjects had detectable concentrations of ketorolac in their plasma (range 11 to 23 ng/mL) at Day 10 during topical ocular treatment. The range of concentrations following three times daily dosing of 0.5% ketorolac tromethamine ophthalmic solution are approximately 4 to 8% of the steady state mean minimum plasma concentration observed following four times daily oral administration of 10 mg ketorolac in humans (290 &plusmn; 70 ng/mL).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>-</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Carboxymethylcellulose sodium</p><p>&nbsp;Sodium chloride</p><p>&nbsp;Sodium citrate dehydrate</p><p>&nbsp;Purified water</p><p>&nbsp;Sodium hydroxide and/or hydrochloric acid to adjust ph.</p><p>&nbsp;</p><p>&nbsp;</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Not known.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Unopened: 24 months
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>&nbsp;</p><p>Store below 30&deg; C. Store the vials in the pouch, protected from light. Fold pouch ends closed. The solution from one individual single-dose vial is to be used immediately after opening. The remaining vial contents should be discarded.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><strong>ACUVAIL </strong>(ketorolac tromethamine ophthalmic solution) 0.45% is supplied as sterile, clear, and colorless to pale yellow ophthalmic solution in clear low density polyethylene (LDPE), single-dose vials packaged in 3 flow wrap pouches, 10 vials per flow Wrap pouch:</p><p>&nbsp;</p><p>30 Single-dose Vials 0.4 mL each (Carton containing 3 flow wraps).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No special requirements.</p><p>Any unused medicinal product or waste material should be disposed of in accordance with local requirements</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                AbbVie Inc.
1 North Waukegan Road
North Chicago, IL 60064 USA


            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                May 2024
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>